Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,144.00
+1.00 (0.09%)
Inactive · Last trade price on Jun 11, 2026
Takara Bio Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 137,755 | 138,237 | 99,704 | 116,803 | 208,680 | 269,851 | |
Market Cap Growth | 46.48% | 38.65% | -14.64% | -44.03% | -22.67% | -24.50% |
Enterprise Value | 128,589 | 128,684 | 71,307 | 81,750 | 177,958 | 234,684 |
Last Close Price | 1144.00 | 1148.00 | 828.00 | 950.98 | 1669.70 | 2107.38 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 95.78 | 78.92 | 13.03 | 13.60 |
Forward PE | - | 25.36 | 38.22 | 21.74 | 20.64 | 19.58 |
PS Ratio | 3.42 | 3.43 | 2.21 | 2.69 | 2.67 | 3.99 |
PB Ratio | 1.32 | 1.33 | 0.86 | 1.05 | 1.86 | 2.81 |
P/TBV Ratio | 1.75 | 1.75 | 0.93 | 1.13 | 2.02 | 3.11 |
P/FCF Ratio | - | - | - | - | 6.70 | - |
P/OCF Ratio | 38.46 | 38.59 | 17.06 | 68.27 | 5.66 | 38.63 |
PEG Ratio | - | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.19 | 3.19 | 1.58 | 1.88 | 2.28 | 3.47 |
EV/EBITDA Ratio | 236.38 | 236.55 | 10.57 | 10.19 | 7.04 | 7.10 |
EV/EBIT Ratio | - | - | 31.51 | 27.22 | 8.66 | 8.12 |
EV/FCF Ratio | - | - | - | - | 5.71 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.11 | 0.11 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 20.19 | 20.19 | 0.16 | 0.12 | 0.04 | 0.03 |
Debt / FCF Ratio | - | - | - | - | 0.03 | - |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.25 | -0.31 | -0.45 | -0.23 |
Net Debt / EBITDA Ratio | -17.40 | -17.40 | -4.22 | -4.29 | -2.01 | -0.68 |
Net Debt / FCF Ratio | 1.05 | 1.05 | 7.06 | 3.11 | -1.63 | 4.17 |
Asset Turnover | 0.31 | 0.31 | 0.37 | 0.35 | 0.64 | 0.66 |
Inventory Turnover | 1.67 | 1.67 | 1.56 | 1.45 | 1.90 | 1.11 |
Quick Ratio | 4.01 | 4.01 | 6.11 | 6.52 | 4.47 | 2.38 |
Current Ratio | 5.76 | 5.76 | 8.09 | 8.76 | 5.40 | 3.92 |
Return on Equity (ROE) | -8.69% | -8.69% | 0.95% | 1.35% | 15.39% | 23.37% |
Return on Assets (ROA) | -2.31% | -2.31% | 1.15% | 1.50% | 10.48% | 17.58% |
Return on Invested Capital (ROIC) | -5.14% | -5.25% | 1.49% | 2.29% | 23.00% | 34.00% |
Return on Capital Employed (ROCE) | -3.80% | -3.80% | 1.90% | 2.60% | 17.90% | 29.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -6.97% | -6.94% | 1.04% | 1.27% | 7.67% | 7.36% |
FCF Yield | -6.55% | -6.52% | -4.04% | -9.47% | 14.93% | -2.01% |
Dividend Yield | 1.49% | - | 2.05% | 1.79% | 2.51% | 1.57% |
Payout Ratio | - | - | 196.73% | 341.35% | 24.78% | 9.69% |
Total Shareholder Return | 1.49% | - | 2.05% | 1.79% | 2.51% | 1.57% |